Text message program to ease mood and behavior symptoms in mild cognitive impairment
Tests an automated instant message program for people with mild cognitive impairment.
Key facts
- Who runs it
- The University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment
- Status
- Recruiting
- People taking part
- 160 people, planned
- Started
- 8 Dec 2025
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- automated instant message-guided neuropsychiatric symptoms management
- general mental health management
- Record updated
- 18 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 50 or older with mild cognitive impairment (mild memory and thinking problems) and mood or behaviour symptoms. It tests a support program sent by instant messages on a smartphone.
- Age
- 50 years and older
- Sex
- All sexes
- Disease stage
- Mild cognitive impairment. HK-MoCA memory and thinking test score from 18 to 22. People must live in the community, not in care.
- Earlier treatment
- People cannot join if they are now in a psychological or behaviour program for these symptoms, or taking psychiatric medicine.
- Biomarker or test result
- Test scores asked for: HK-MoCA 18 to 22, MBI-C ≥7, SCD-9 ≥3, IADL =18.
Main reasons for not taking part
- Diagnosis of dementia
- Diagnosis of a psychiatric disease
- Now taking psychiatric medicine
- Now in a psychological or behaviour program for these symptoms
- Now in acute care or care after a hospital stay
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Community-dwelling adults aged ≥ 50 years
- HK-MoCA score ranged from 18 to 22
- MBI-C ≥7
- SCD-9 ≥3
- IADL =18
- Able to read and communicate in Chinese
- Able to use the text or voice messaging function on a smartphone
Who cannot take part
- Currently taking psychiatric medication
- Currently receiving acute care or post-acute hospitalization care
- Clinical diagnosis of dementia
- Clinical diagnosis of psychiatric disease
- Currently participating in any type of psychological or behavioural intervention for NPSs
This trial is currently available in Hong Kong.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to develop an automated instant message-delivered intervention (i.e., EMI) for people with mild cognitive impairment to reduce their NPS, and to investigate the feasibility and effectiveness of the intervention.
The 2 groups in the trial
- Intervention groupTreatment being tested
Participants in intervention group will receive the EMI for 9 weeks. Based on the steps of mobile message development recommended by Abroms, et al., our multidisciplinary team - including a neurologist, nurses, clinical psychologists and gerontologists - will develop an ACT message content library and protocol for IM delivery (i.e. EMI).
Treatment: automated instant message-guided neuropsychiatric symptoms management
- Control groupExisting treatment, for comparison
The control group will receive instant messages about general mental health management from the HKSAR Government website in 9 weeks, which is open to the public (https://www.shallwetalk.hk/en/mental-well-being/mental-well-being-is-related-to-you/), with reminder text messages of follow-up surveys.
Treatment: general mental health management
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Instant Message-delivered Personalised Acceptance and Commitment Therapy (IMPACT) for Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment: a Mixed Methods Study
- Plain-language title
- Text message program to ease mood and behavior symptoms in mild cognitive impairmentGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 18 May 2026